Forest Laboratories, Inc. - FRX - Financial Statement Analysis

All financial statement analysis reports for your requested company can be accessed below. The SIC # column is the SIC Code for the industry under which the current company is analyzed. When a report is purchased the SIC Code indicated is the industry that the company displayed will be compared against. If a different industry is desired for comparison, purchase of a separate industry analysis is suggested.

In addition to the ratio analysis reports, the latest business news headlines involving your company or industry sector are hyperlinked for your convenience along with the stock ticker for the company displayed.

Financial statement analysis updated: May 19, 2013

Forest Laboratories, Inc. - SIC # 2834

Ticker	Exchange	SIC #	Website	Latest Ticker
FRX	New York	2834	http://www.frx.com/	38.43 +0.92
Select one of the five (5) financial statement analysis reports below to view the ratio analysis report for your selected company: Publicly Traded Company Industry Ratios Publicly Traded Company VS. Industry Ratios Publicly Traded Company VS Publicly Traded Company Private Company VS Publicly Traded Company
Latest Headlines for Forest Laboratories, Inc. Forest Labs CEO Howard Solomon to retire - May 23rd, 2013 8:34 am Forest Labs CEO Howard Solomon to retire - May 23rd, 2013 8:34 am Oakmark Fund Buys Forest Laboratories, DirecTV, UnitedHealth, Apple - May 23rd, 2013 7:43 am Forest Labs' longtime CEO Solomon to step down at year-end - May 23rd, 2013 7:40 am Forest Laboratories Says Solomon to Leave CEO Post - May 23rd, 2013 6:09 am InPlay: Forest Labs provides update on succession planning; Howard Solomon to retire as CEO and President at end of 2013; will serve as chairman to 2014 AGM and then become Chairman Emeritus - May 23rd, 2013 6:04 am Forest Laboratories Provides Update on Succession Planning - May 23rd, 2013 6:00 am Will Ranbaxy Labs Be Excluded From Medicare And Medicaid? - May 22nd, 2013 4:04 pm Did Apple Pare Its Tax Bill With a 'Double Irish?' - May 22nd, 2013 11:08 am Apple Got No Sweetheart Accord on Corporate Tax Bill, Irish Say - May 22nd, 2013 5:35 am Google Joins Apple Avoiding Taxes With Stateless Income - May 21st, 2013 10:15 pm Synergy Is A Straightforward Opportunity: Trial Results At DDW Back Plecanatide - May 21st, 2013 11:41 am Is There a Pill For That? Forest Labs’ Iffy Pipeline - May 21st, 2013 7:27 am Teva Bets on Reformulating Old Drugs as Investors Say ‘Show Me’ - May 20th, 2013 3:01 pm July Options Now Available For Forest Laboratories (FRX) - May 20th, 2013 11:56 am Forest to Present Aclidinium Bromide and Roflumilast Clinical Data at the American Thoracic Society (ATS) International Conference - May 17th, 2013 6:08 am Finny Kuruvilla, Portfolio Manager of the Eventide Gilead Fund, Interviews with The Wall Street Transcript: Investing in Health Care Innovation - May 16th, 2013 11:23 am Forest Laboratories, Inc. to Present Data from Cariprazine and Levomilnacipran Phase 3 Trials at American Psychiatric Association Annual Meeting - May 16th, 2013 6:00 am Forest Reaches New 52-Week High (FRX) - May 14th, 2013 9:59 am Forest-Trevena Ink Deal - May 14th, 2013 9:10 am View All Current Headlines >>